{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:12:58Z","timestamp":1778584378555,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["GRANT004_94839"],"award-info":[{"award-number":["GRANT004_94839"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009467","name":"University of the Witwatersrand, Johannesburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001336","name":"University of the Witwatersrand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cyto.2022.155945","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T13:49:14Z","timestamp":1657720154000},"page":"155945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa"],"prefix":"10.1016","volume":"157","author":[{"given":"Anastasia","family":"Gandini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"De Maayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Munien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maemu P.","family":"Gededzha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth S.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cyto.2022.155945_b0005","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.humimm.2021.07.015","article-title":"Diagnosing coeliac disease: A literature review","volume":"82","author":"Gandini","year":"2021","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155945_b0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cyto.2022.155945_b0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.52.2.218","article-title":"Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function","volume":"52","author":"Clemente","year":"2003","journal-title":"Gut."},{"issue":"9","key":"10.1016\/j.cyto.2022.155945_b0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nri885","article-title":"Coeliac disease: dissecting a complex inflammatory disorder","volume":"2","author":"Sollid","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"9381","key":"10.1016\/j.cyto.2022.155945_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet."},{"issue":"142","key":"10.1016\/j.cyto.2022.155945_b0030","first-page":"1","article-title":"Celiac disease: a comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.cyto.2022.155945_b0035","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2036.2007.03502.x","article-title":"Increasing prevalence of coeliac disease over time","volume":"26","author":"Lohi","year":"2007","journal-title":"Aliment Pharmacol. Ther."},{"issue":"25","key":"10.1016\/j.cyto.2022.155945_b0040","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1056\/NEJMe030050","article-title":"Celiac Disease - How to Handle a Clinical Chameleon","volume":"348","author":"Fasano","year":"2003","journal-title":"N Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cyto.2022.155945_b0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5505\/ejm.2019.26122","article-title":"Extraintestinal Manifestations Associated with Celiac Disease","volume":"24","author":"Kayar","year":"2019","journal-title":"Eastern J. Med."},{"key":"10.1016\/j.cyto.2022.155945_b0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-0039.1990.tb01816.x","article-title":"The primary association of celiac disease to a given HLA-DQ \u03b1\/\u03b2 heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations","volume":"36","author":"Sollid","year":"1990","journal-title":"Tissue Antigens."},{"issue":"3","key":"10.1016\/j.cyto.2022.155945_b0055","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0016-5085(93)90912-V","article-title":"HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis","volume":"105","author":"Sollid","year":"1993","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.cyto.2022.155945_b0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa1313977","article-title":"Risk of pediatric celiac disease according to HLA haplotype and country","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl. J. Med."},{"issue":"9","key":"10.1016\/j.cyto.2022.155945_b0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.dld.2017.06.010","article-title":"Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases","volume":"49","author":"Di Sabatino","year":"2017","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.cyto.2022.155945_b0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2796.2004.01406.x","article-title":"Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance","volume":"256","author":"Midhagen","year":"2004","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.cyto.2022.155945_b0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/j.gastro.2017.05.015","article-title":"Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis","volume":"153","author":"Silvester","year":"2017","journal-title":"Gastroenterology."},{"key":"10.1016\/j.cyto.2022.155945_b0080","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/gut.21.11.1010","article-title":"Adenocarcinoma of the upper small bowel complicating coeliac disease","volume":"21","author":"Holmes","year":"1980","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cyto.2022.155945_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112551","article-title":"CX3CL1-CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis","volume":"11","author":"Fernandez-Prieto","year":"2019","journal-title":"Nutrients."},{"issue":"7","key":"10.1016\/j.cyto.2022.155945_b0090","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ajg.2016.162","article-title":"Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge","volume":"111","author":"Adriaanse","year":"2016","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.cyto.2022.155945_b0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2022.155945_b0100","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1038\/s41598-017-07242-4","article-title":"Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP","volume":"7","author":"Adriaanse","year":"2017","journal-title":"Sci. Rep."},{"issue":"14303","key":"10.1016\/j.cyto.2022.155945_b0105","first-page":"1","article-title":"A Phospholipid Profile at 4 Months Predicts the Onset of Celiac Disease in at-Risk Infants","volume":"9","author":"Auricchio","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cyto.2022.155945_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm8060885","article-title":"Non-Invasive Biomarkers for Celiac Disease","volume":"8","author":"Singh","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2022.155945_b0115","first-page":"87","article-title":"Intestinal fatty acid binding protein (I-FABP) as a promising test for Crohn's disease: a preliminary study","volume":"61","author":"Sarikaya","year":"2015","journal-title":"Clin. Lab."},{"issue":"5","key":"10.1016\/j.cyto.2022.155945_b0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mi.10.5.3","article-title":"Fractalkine\/CX3CL1: a potential new target for inflammatory diseases","volume":"10","author":"Jones","year":"2010","journal-title":"Mol. Interv."},{"issue":"1\u20133","key":"10.1016\/j.cyto.2022.155945_b0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.regpep.2007.12.002","article-title":"Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis","volume":"147","author":"Wiercinska-Drapalo","year":"2008","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.cyto.2022.155945_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1388-1981(00)00046-9","article-title":"The fatty acid transport function of fatty acid-binding proteins","volume":"1486","author":"Storch","year":"2000","journal-title":"Biochim. Biophys. Acta."},{"issue":"11","key":"10.1016\/j.cyto.2022.155945_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081318","article-title":"Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population","volume":"8","author":"Ishimura","year":"2013","journal-title":"PLOS ONE."},{"issue":"3","key":"10.1016\/j.cyto.2022.155945_b0140","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jgh.14852","article-title":"Non-immunological biomarkers for assessment of villous abnormalities in patients with celiac disease","volume":"35","author":"Singh","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cyto.2022.155945_b0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell."},{"issue":"6617","key":"10.1016\/j.cyto.2022.155945_b0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature."},{"key":"10.1016\/j.cyto.2022.155945_b0155","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","author":"Lopez","year":"2007"},{"issue":"2","key":"10.1016\/j.cyto.2022.155945_b0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/jca.47022","article-title":"Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review","volume":"12","author":"Rivas-Fuentes","year":"2021","journal-title":"J Cancer."},{"issue":"9","key":"10.1016\/j.cyto.2022.155945_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0185025","article-title":"Immunopathology of childhood celiac disease - Key role of intestinal epithelial cells","volume":"12","author":"Pietz","year":"2017","journal-title":"PLOS One."},{"issue":"10","key":"10.1016\/j.cyto.2022.155945_b0170","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/rheumatology\/ken197","article-title":"Fractalkine in rheumatoid arthritis: a review to date","volume":"47","author":"Murphy","year":"2008","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"10.1016\/j.cyto.2022.155945_b0175","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/dmrr.1257","article-title":"Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity","volume":"27","author":"Takahashi","year":"2011","journal-title":"Diabetes Metab. Res."},{"issue":"1","key":"10.1016\/j.cyto.2022.155945_b0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol."},{"issue":"4","key":"10.1016\/j.cyto.2022.155945_b0185","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.immuni.2009.08.023","article-title":"How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets","volume":"31","author":"Feuerer","year":"2009","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.cyto.2022.155945_b0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jgh.14596","article-title":"Prevalence and characteristics of celiac disease in South African patients with type 1 diabetes mellitus: Results from the Durban Diabetes and Celiac Disease Study","volume":"34","author":"Paruk","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.cyto.2022.155945_b0195","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11892-014-0517-x","article-title":"Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis","volume":"14","author":"Cohn","year":"2014","journal-title":"Curr. Diab. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2022.155945_b0200","first-page":"441","article-title":"A Retrospective Study on Human Leukocyte Antigen Types and Haplotypes in a South African Population","volume":"145","author":"Gandini","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.cyto.2022.155945_b0205","article-title":"Coeliac disease high-risk HLA alleles in a South African type one diabetic population","author":"Gandini","year":"2022","journal-title":"Under publication."},{"issue":"10","key":"10.1016\/j.cyto.2022.155945_b0210","doi-asserted-by":"crossref","DOI":"10.7196\/SAMJ.2021.v111i10.15680","article-title":"The prevalence of coeliac disease-associated human leukocyte antigens in South African transplant donors and recipients","volume":"111","author":"Mrubata","year":"2021","journal-title":"S Afr. Med. J."},{"key":"10.1016\/j.cyto.2022.155945_b0215","series-title":"Biochemistry of Lipids, Lipoproteins and Membranes","first-page":"149","article-title":"Chapter 5 - Fatty Acid Handling in Mammalian Cells","author":"Lehner","year":"2016"},{"issue":"1","key":"10.1016\/j.cyto.2022.155945_b0220","doi-asserted-by":"crossref","first-page":"34371","DOI":"10.1038\/srep34371","article-title":"Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis","volume":"6","author":"Sun","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cyto.2022.155945_b0225","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.4049\/jimmunol.164.6.3368","article-title":"Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa","volume":"164","author":"Muehlhoefer","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155945_b0230","doi-asserted-by":"crossref","unstructured":"Dadfar E, Ghaderi A, Moshfegh A, Barcenilla H, Casas R, Samuelsson U. Reduced level of CX3CR1 positive T-cells and monocytes in children with, newly diagnosed, Type 1 diabetes. J Immunol. 2020;204(1):59.7.","DOI":"10.4049\/jimmunol.204.Supp.59.7"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:29:48Z","timestamp":1778581788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S1043466622001545"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155945","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal fatty acid binding protein (I-FABP) and CXC3L1 evaluation as biomarkers for patients at high-risk for coeliac disease in Johannesburg, South Africa","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155945"}}